ClinicalTrials.gov
ClinicalTrials.gov Menu

Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00128778
Recruitment Status : Completed
First Posted : August 10, 2005
Last Update Posted : September 5, 2007
Sponsor:
Collaborator:
Schering-Plough
Information provided by:
Spanish Breast Cancer Research Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : December 2006